US Patent Issued to DANA-FARBER CANCER INSTITUTE on Nov. 11 for "Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,869, issued on Nov. 11, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies" was invented by Carl Novina (Newton, Mass.), Robert J. Distel (Framingham, Mass.), Alberto Nobili (Brookline, Mass.) and Steven C. Neier (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions and methods for treating cancers characterized by the presence of solid tumors, which simultaneously target a plurality of targets on cancer cells using single CAR T construct."

The patent was filed on June 27, 2019, under Application No. 17/254,472. ...